Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,995
Total Claims
$308K
Drug Cost
155
Beneficiaries
$1,989
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
+76%
Cost per patient vs peers
$1,989 vs $1,128 avg
+20%
Brand preference vs peers
10.1% vs 8.4% avg
Brand vs Generic
Brand: 899 claims · $195K
Generic: 7,989 claims · $111K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Insulin Glargine,hum.Rec.Anlog | 94 | $32K |
| Sitagliptin Phosphate | 37 | $25K |
| Rivaroxaban | 26 | $16K |
| Sitagliptin Phos/Metformin Hcl | 22 | $12K |
| Levothyroxine Sodium | 241 | $12K |
| Dulaglutide | 12 | $11K |
| Sitagliptin Phos/Metformin Hcl | 13 | $8,216 |
| Insulin Nph Human Isophane | 25 | $7,573 |
| Insulin Nph Hum/Reg Insulin Hm | 29 | $6,984 |
| Insulin Lispro Protamin/Lispro | 11 | $6,552 |
| Diclofenac Epolamine | 16 | $5,852 |
| Insulin Nph Hum/Reg Insulin Hm | 12 | $5,809 |
| Bimatoprost | 19 | $4,570 |
| Candesartan/Hydrochlorothiazid | 44 | $4,136 |
| Betamethasone Dipropionate | 41 | $3,905 |
Prescribing Profile
Patient Profile
70
Avg Age
62%
Female
1.72
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data